The journal Regenerative Medicine has published a special focus issue on methods to avoid immune rejection in regenerative medicine.
The immunology of regenerative medicine is an immature discipline, yet it is of profound importance that research continues in this field. Stem cells are increasingly used in the research of potential therapies and cures, and the issue of immunity is an essential part of the progress and development of regenerative medicine. This issue of Regenerative Medicine therefore provides great insight into the interface between stem cell biology and immunology - to bring cell therapies into the clinic we must overcome challenges such as immunological rejection.
"By bringing together a broad range of expertise in immunology and stem cell biology, we hope that this Special Focus Issue will highlight the immunological challenges that lie ahead for regenerative medicine, stimulate productive dialog between the two fields and open up new avenues of research. Only through such interdisciplinary collaboration will solutions ultimately be found."
"Since RegMedNet is rapidly becoming the pre-eminent forum in which to discuss issues relevant to regenerative medicine, I am particularly pleased to be able to use it to announce the publication of the Regenerative Medicine Special Focus Issue devoted to the immunological issues that face this emerging field." said Professor Fairchild (Sir William Dunn School of Pathology, University of Oxford, UK, and guest editor of this issue).
Elena Conroy, Commissioning Editor of Regenerative Medicine, commented: "I hope the articles included in this issue will highlight the importance of immunology in regenerative medicine, as well as encouraging debate and discussion ? hopefully leading to more progress and collaboration in the future."
Titled 'Immunological challenges and opportunities in regenerative medicine', the issue includes an article by a number of collaborating authors including Sir Ian Wilmut and Professor Shynia Yamanaka focusing on proposals for the generation of a global haplobank of GMP-compliant induced pluripotent stem cell lines to facilitate matching between donor and recipient, in addition to an interview and profile on the new UKRMP "immunomodulation hub" collaboration.
The special focus issue can be viewed here - http://www.
An exclusive interview with Professor Fairchild is also available on Regenerative Medicine's sister website, RegMedNet. Paul shares his hopes for what this special focus issue will achieve and where the field will be in the next 5 years. Watch the interview here - https:/
About Regenerative Medicine
Regenerative Medicine (Impact Factor 3.5 - 2013) provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats - vital to an increasingly time-constrained community.
- Bench-to-bedside translation and scale-up of stem cell and regenerative medicine therapies
- Potential applications for stem cell-based strategies in pathological conditions
- Stem cell pluripotency and emerging technologies
- Tissue engineering and artificial organ development
- Regulatory and reimbursement issues
- Ethical and legal perspectives
Despite substantial developments in our knowledge and understanding of stem cell biology and regenerative medicine, the field is in its infancy. The next few decades will unveil the true potential of this emerging specialty. Regenerative Medicine will provide a critical overview of these advances as they unfold and explore their potential relevance in the clinical setting.
Launched in December 2014, RegMedNet is the first of a suite of online networks from Future Science Group focusing on a range of aspects in medicinal and scientific discovery and enterprise. RegMedNet is free to join for all those specializing in regenerative medicine and related fields, and mixes user-generated content with specially curated content from the community manager, as well as providing networking opportunities and peer-to-peer engagement to really drive this exciting field forward. http://www.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.